"Does the Farber departure change things? Absolutely. I would say, however, our commitment remains to patients," Mass General Brigham CEO Anne Klibanski told STAT.
Check out more exclusive coverage with a STAT+ subscription | Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles. |
|
| STAT, 1 Exchange Place, Boston, MA | ©2024, All Rights Reserved. | |
|
No comments